🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

The Second Hospital of Nanjing Medical University clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our China register with The Second Hospital of Nanjing Medical University as lead sponsor. Synced 26 Sep 2026
32Current trials
21Recruiting now
3Drugs in these trials
1Trial register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

The Second Hospital of Nanjing Medical University is the lead sponsor of 32 current clinical trials in our China register. 21 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Washed Microbiota Transplantation, CMTS0929 and Mesalazine. The most-studied condition is Malnutrition.

ClinicalTrials.gov trials by status

  • Recruiting2166%
  • Not yet open928%
  • Active, closed26%

Trials by phase

  • Not applicable1031%
  • Observational928%
  • Phase 1/2722%
  • Phase EARLY_PHASE139%
  • Phase 226%
  • Phase 113%
01

Clinical trials sponsored by The Second Hospital of Nanjing Medical University

32 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Washed Microbiota Transplantation Combined With Enteral Nutrition for Gastroptosis
NCT06837194 · ClinicalTrials.gov ↗ · Gastroptosis, Malnutrition
Observational Recruiting 2025-02 China
Fluorouracil Treatment Via Colon for Colorectal Cancer
NCT06385418 · ClinicalTrials.gov ↗ · Colorectal Cancer
Phase 2 Recruiting 2024-05 China
Study of CMTS1215 Injection in Patients With Solid Tumors
NCT07556276 · ClinicalTrials.gov ↗ · Solid Tumor
Phase 1/2 Recruiting 2025-03 China
Rescue Fecal Microbiota Transplantation for National Refractory Intestinal Infections
NCT03895593 · ClinicalTrials.gov ↗ · Intestinal Infection, Clostridioides Difficile Infection, Antibiotic-associated Diarrhea
Observational Recruiting 2015-09 China
ND-12 Combined With H-6 for Adult Chronic Inflammatory Diarrhea
NCT07767370 · ClinicalTrials.gov ↗ · Diarrhea Chronic, UC - Ulcerative Colitis
Phase EARLY_PHASE1 Recruiting 2026-07 China
Gut Oxygen Therapy for Ischemic-Hypoxic Bowel Disease
NCT07621367 · ClinicalTrials.gov ↗ · Chronic Ischemic-Hypoxic Enteropathy
Not applicable Recruiting 2026-08 China
WMT for Autism Spectrum Disorder (ASD)
NCT06030752 · ClinicalTrials.gov ↗ · Autism Spectrum Disorder
Observational Recruiting 2023-09 China
Fecal Microbiota Transplantation for Radiation Enteritis
NCT03516461 · ClinicalTrials.gov ↗ · Radiation Enteritis
Not applicable Recruiting 2018-01 China
Washed Microbiota Transplantation for the Treatment of Oncotherapy-Related Intestinal Complications
NCT04721041 · ClinicalTrials.gov ↗ · Intestinal Complications, Cancer
Not applicable Recruiting 2021-01 China
Washed Microbiota Transplantation for Clostridioides Difficile Infection
NCT06106698 · ClinicalTrials.gov ↗ · Clostridioides Difficile Infection
Observational Recruiting 2023-07 China
Effect and Mechanism of Baitouweng Decoction for Large Intestine Damp-heat Syndrome of Ulcerative Colitis
NCT06421818 · ClinicalTrials.gov ↗ · Ulcerative Colitis
Phase 2 Recruiting 2024-05 China
Total Parathyroidectomy With Autotransplantation Versus Total Parathyroidectomy Alone for Secondary Hyperparathyroidism
NCT04922892 · ClinicalTrials.gov ↗ · Secondary Hyperparathyroidism;Parathyroidectomy
Not applicable Recruiting 2021-06 China
Washed Microbiota Transplantation for Diabetic Gastroparesis
NCT06340217 · ClinicalTrials.gov ↗ · Diabetic Gastroparesis
Not applicable Recruiting 2024-04 China
Washed Microbiota Transplantation for Malnutrition
NCT06447220 · ClinicalTrials.gov ↗ · Malnutrition
Observational Recruiting 2023-12 China
Washed Microbiota Transplantation for Food Intolerance
NCT07190183 · ClinicalTrials.gov ↗ · Food Intolerance
Observational Recruiting 2025-01 China
Microbiota Transplantation in Solid Organ Transplantation
NCT06730451 · ClinicalTrials.gov ↗ · Solid Organ Transplant Complications
Observational Recruiting 2018-01 China
Washed Microbiota Transplantation for Type 1 Diabetes Mellitus
NCT06256614 · ClinicalTrials.gov ↗ · Type 1 Diabetes
Observational Recruiting 2024-03 China
Washed Microbiota Transplantation for Attention-deficit/Hyperactivity Disorder
NCT06376331 · ClinicalTrials.gov ↗ · Attention-deficit/Hyperactivity Disorder
Observational Recruiting 2024-04 China
Washed Microbiota Transplantation for Tourette's Syndrome
NCT03764748 · ClinicalTrials.gov ↗ · Tourette Syndrome
Phase 1 Recruiting 2024-04 China
Washed Microbiota Transplantation for Malnutrition After Nonphysiological Reconstruction of the Upper Gastrointestinal Tract
NCT05439135 · ClinicalTrials.gov ↗ · Malnutrition, Gastroenterostomy
Not applicable Recruiting 2024-10 China
Washed Microbiota Transplantation for Chronic Constipation in Adults
NCT06106685 · ClinicalTrials.gov ↗ · Constipation
Phase 1/2 Recruiting 2023-07 China
CMTS4520-Assisted Washed Microbiota Transplantation for Chronic Constipation in Adults
NCT06832176 · ClinicalTrials.gov ↗ · Constipation
Phase 1/2 Not yet open 2025-02 China
Washed Microbiota Transplantation Alleviates Diabetic Gastrointestinal Motility Disorders: an Efficacy and Safety Study
NCT06340828 · ClinicalTrials.gov ↗ · Diabetic Gastroparesis, Diabetic Gastropathy, Diabetic Gastroenteropathy
Not applicable Not yet open 2024-04 China
Washed Microbiota Transplantation for Allergic Rhinitis
NCT06372184 · ClinicalTrials.gov ↗ · Rhinitis, Allergic
Not applicable Not yet open 2024-06 China
CMTS0929 for Inflammatory Bowel Disease
NCT06844708 · ClinicalTrials.gov ↗ · Inflammatory Bowel Disease (IBD)
Drug: CMTS0929
Phase EARLY_PHASE1 Not yet open 2025-02 China
Washed Microbiota Transplantation for Rhinitis
NCT06350448 · ClinicalTrials.gov ↗ · Rhinitis
Not applicable Not yet open 2024-05 China
CMTS0929 for Clostridioides Difficile Infection
NCT06836427 · ClinicalTrials.gov ↗ · Clostridioides Difficile Infection
Drug: CMTS0929
Phase EARLY_PHASE1 Not yet open 2025-02 China
CMTS4520-Assisted Washed Microbiota Transplantation for Chronic Diarrhoea in Adults
NCT06839599 · ClinicalTrials.gov ↗ · Diarrhea
Phase 1/2 Not yet open 2025-02 China
Washed Microbiota Transplantation in Solid Organ Transplantation
NCT06708676 · ClinicalTrials.gov ↗ · Solid Organ Transplant Complications
Not applicable Not yet open 2024-11 China
CMTS4520 for Chronic Constipation in Adults
NCT06832137 · ClinicalTrials.gov ↗ · Constipation
Phase 1/2 Not yet open 2025-03 China
CMTS4520 for Chronic Diarrhoea in Adults
NCT06839586 · ClinicalTrials.gov ↗ · Diarrhoea
Phase 1/2 Active, closed 2025-02 China
CMTS0515-auWMT for Radiation Enteritis
NCT07331688 · ClinicalTrials.gov ↗ · Radiation Enteritis
Phase 1/2 Active, closed 2025-12 China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in The Second Hospital of Nanjing Medical University trials

3 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in The Second Hospital of Nanjing Medical University trials

32 conditions
Malnutrition3Constipation3Clostridioides Difficile Infection3Diabetic Gastroparesis2Radiation Enteritis2Solid Organ Transplant Complications2Gastroptosis1Colorectal Cancer1Diabetic Gastropathy1Diabetic Gastroenteropathy1Diabetic Gastroparesis Associated With Type 2 Diabetes Mellitus1Solid Tumor1Intestinal Infection1Antibiotic-associated Diarrhea1Rhinitis, Allergic1Diarrhea Chronic1UC - Ulcerative Colitis1Diarrhoea1Chronic Ischemic-Hypoxic Enteropathy1Inflammatory Bowel Disease (IBD)1Autism Spectrum Disorder1Intestinal Complications1Cancer1Ulcerative Colitis1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in China3221

A trial with sites in more than one country appears in each of those registers.

05

Other sponsors in Malnutrition

SponsorTrials
Peking Union Medical College2
Nutricia UK1

Sponsors with the most current trials registered for this condition.

06

Questions about The Second Hospital of Nanjing Medical University trials

How many clinical trials does The Second Hospital of Nanjing Medical University sponsor?

The Second Hospital of Nanjing Medical University is the lead sponsor of 32 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are The Second Hospital of Nanjing Medical University trials recruiting?

Yes. 21 of its 32 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is The Second Hospital of Nanjing Medical University testing?

Its current trials name 3 drugs and biologicals as interventions. The most frequent are Washed Microbiota Transplantation (5), CMTS0929 (2) and Mesalazine (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.